PharmaLinkFHI has announced the acquisition of a UK-based clinical
research organisation (CRO) called Matrix, as consolidation within
this industry sector continues.
Only months after having its first offer rejected, ClinPhone has
finally agreed to a deal allowing Parexel to acquire the firm.
However Quintiles has indicated it may make a play to outbid its
rival.
Encorium Group has just announced its intention to acquire an
oncology-focused contract research organisation (CRO), along with
plans to merge with another entity that will offer it a wider
global reach.
Russia has witnessed a drop in generating new business activity on
the clinical trials scene over the past year, but has been
increasing its own activity in this field.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving MDS Pharma Services,
Almac Clinical Technologies and Pharm-Olam International.
Synexus has been making business strides of late, thanks to its
"innovative" model for patient recruitment and monitoring
for late stage clinical trials.
Australia's clinical trial industry is taking steps to promote
itself further on the world stage, along with the forging of closer
ties with the budding Asia-Pacific region.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving Chiltern, Veeda
Oncology, Icon Clinical and Pharmanet.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving Tigermed Consulting,
Lifetree Clinical Research, Synexus and Anapharm.
Quintiles Transnational has heralded the results of an
independently conducted study of clinical investigator sites across
Europe that saw the firm rate the highest overall in terms of
satisfaction.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving eResearchTechnology
and nSpire Health, i3 Research and Clinsys Clinical Research.
Three Indian contract research organisations (CROs) - Asian
Clinical Trials (ACT), Veeda Clinical Research and Siro Clinpharm
have made recent global moves in order to add more muscle to their
industry presence.
Chiltern has become the latest in a growing number of contract
research organisations (CROs) to establish a foothold within the
clinical sleeping giant that is Russia.
The US Food and Drug Administration (FDA) has revealed it will be
operating on the ground in China imminently, while the Drug
Information Association (DIA) has just planted itself in Asia's
other pharma don, India.
At present India appears to be beating China in the race for Asia's
top clinical spot, according to new figures published by india´s
Planning Commission.
Overall, 2007 was another stellar year for contract service
providers, particularly those at the early-stage end of
development, although companies are advised to watch out for a
tougher environment ahead.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving CRI Worldwide,
Pacific Biometrics, Encorium Group and Cato research.
Despite all the hype over clinical trial offshoring, the US still
dwarfs the scene, with emerging countries as yet only a blip on the
radar, a unique new study reveals.
Malaysia's pharmaceutical star is likely to rise as of this year,
with an eventual position being gained amongst some of the world's
industry leaders being predicted by Frost & Sullivan.
Synchron Research has revealed it is close to opening up new
operations in Vietnam and Hong Kong - within the next six months -
and has just bought a new business in France and strengthened its
ties with Parexel.
Quintiles has forged a new partnership that will allow it to begin
providing central laboratory services in Japan, where the clinical
research organisation (CRO) industry is gaining momentum.
The pharmaceutical industry in the UK faces tougher legislation on
the disclosure of adverse events in clinical trials following the
MHRA's thwarted attempt to prosecute GlaxoSmithKline for allegedly
withholding information about...
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving PRA International
and Premier Research.
inVentiv Clinical has become the latest contract research
organisation (CRO) to open up shop in blossoming Latin America in a
bid to gain more of a global reach.
The prospects for a viable market in inhaled insulin therapies were
looking markedly thinner this week after Eli Lilly pulled the plug
on its joint development programme with drug delivery specialist
Alkermes for AIR Insulin.
A Polish and a Czech firm have merged together in a bid to
strengthen their position in the Central and Eastern Europe's
(CEE's) budding clinical research scene.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving Global Research
Services, Quintiles and Icon.
Pharmaceutical Products Development (PPD) has announced it is
moving into Russia, along with the news of positive trial results
for its statin, although profits dipped again during the fourth
quarter of 2007 as its R&D bill mounts.
MDS Pharma Services is the latest contract research organisation
(CRO) to branch out into a new and exotic emerging market location,
with the establishment of an office in Sao Paulo, Brazil.
Pharmaceutical Product Development (PPD) has initiated central
laboratory services in China in response to the country's budding
clinical trials scene.
Eli Lilly has released a statement strongly objecting to
implications made in a New York Times article that it has
suppressed results of negative clinical trials.
Pfizer is vowing to fight on as Nigerian court battles against its
subsidiary in the country wage on over its alleged involvement in
child deaths through experimentation over a decade ago.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving Encorium Group,
Holmes Biopharma and Novotech.
Although India 'has carved out a significant portion of the world
pharma pie', an enormous change in mindset is needed if the country
is to become a global pharmaceutical hub, according to a new report
from KPMG.
One Equity Partners (OEP), the private equity arm of JPMorgan
Chase, is in the process of selling its stake in Quintiles for a
reported sum of over $3bn.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving PPD, PRA, Accutest
and Premier Research.
MDS Pharma is continuing its efforts to move on from the trouble
caused in its Pharma Services segment by a US Food and Drug
Administration (FDA) review of its Montreal-area bioanalytical
facilities.
Two French contract research organisations (CROs) that specialise
in ophthalmology have banded together to offer specialised services
to this niche market.
US researchers have developed a fast and inexpensive protein
biomarker detection device that could simplify disease diagnosis
and aid in following disease progression in drug trials.
Eisai is planning to step up its clinical research presence in Asia
and has chosen Singapore as a hub from which to coordinate its
research activities.
GVK Bio has reinforced its claim to be India's top contract
research organisation with a 100-crore ($25m) push from a private
investment company. The funds will be used to expand its drug
discovery services and push further into...
New research from Frost & Sullivan provides a snapshot of
biopharma spending trends on contract research organisations
(CROs), along with forecasts for industry growth.
Almac Group today announces the release of the company’s 2023 Corporate Social Responsibility report, which highlights Almac’s progress and commitments...
It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...
The use of internal standards (IS) is essential for developing and applying liquid chromatography-tandem mass spectrometric (LC-MS/MS) quantitative bioanalytical...
